Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Kimberly Simmons

Concepts (127)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Diabetes Mellitus, Type 1
33
2026
3930
3.650
Why?
Autoantibodies
13
2026
1500
1.900
Why?
Insulin-Secreting Cells
6
2026
393
1.630
Why?
Antibodies, Monoclonal, Humanized
7
2026
992
1.360
Why?
Hypoglycemic Agents
4
2026
1412
0.730
Why?
Autoimmunity
4
2026
925
0.660
Why?
Diet, Carbohydrate-Restricted
1
2021
36
0.650
Why?
Diet, Ketogenic
1
2021
40
0.640
Why?
Prediabetic State
1
2023
250
0.630
Why?
HLA-DQ beta-Chains
1
2020
58
0.620
Why?
Health Fairs
1
2019
10
0.600
Why?
Insulin
6
2026
2525
0.580
Why?
Celiac Disease
2
2022
285
0.500
Why?
Child
24
2026
22693
0.500
Why?
Endocrinology
3
2024
77
0.490
Why?
Insulin Antibodies
1
2016
103
0.470
Why?
Adolescent
20
2026
22557
0.460
Why?
Dried Blood Spot Testing
1
2016
129
0.450
Why?
Blood Glucose
2
2026
2360
0.420
Why?
HLA-D Antigens
1
2014
30
0.420
Why?
Diet Therapy
1
2014
36
0.420
Why?
Antibodies
1
2015
400
0.380
Why?
Glucose Tolerance Test
2
2026
360
0.360
Why?
Islets of Langerhans
5
2024
852
0.350
Why?
Bone Density
1
2015
494
0.340
Why?
Mass Screening
1
2019
1307
0.330
Why?
Humans
37
2026
146342
0.320
Why?
Child, Preschool
11
2026
11913
0.320
Why?
C-Peptide
3
2026
191
0.310
Why?
Immunosuppressive Agents
1
2014
829
0.300
Why?
Diabetes Complications
2
2022
219
0.290
Why?
Infant
10
2026
10114
0.280
Why?
Diabetic Ketoacidosis
3
2025
212
0.260
Why?
Thyroiditis, Autoimmune
1
2026
16
0.240
Why?
Risk Assessment
3
2023
3712
0.230
Why?
Male
17
2026
73396
0.230
Why?
Hypothyroidism
1
2026
68
0.230
Why?
Disease Progression
5
2024
2867
0.220
Why?
Thyroid Gland
1
2026
93
0.220
Why?
Female
17
2026
79499
0.220
Why?
HLA Antigens
2
2025
241
0.220
Why?
Herpesvirus 4, Human
1
2026
172
0.210
Why?
Age of Onset
3
2025
558
0.210
Why?
Immunotherapy
1
2026
671
0.170
Why?
Hyperglycemia
1
2024
384
0.160
Why?
Obesity Management
1
2020
12
0.160
Why?
Diagnostic Techniques, Endocrine
1
2019
15
0.150
Why?
Blood Specimen Collection
1
2019
37
0.150
Why?
Clinical Protocols
1
2021
282
0.150
Why?
Quality of Life
2
2023
3200
0.140
Why?
Methylation
1
2019
241
0.140
Why?
Young Adult
5
2025
14330
0.140
Why?
Nutritional Status
1
2021
346
0.140
Why?
Haplotypes
1
2020
506
0.140
Why?
Cell Death
1
2019
379
0.130
Why?
Disease Susceptibility
1
2019
339
0.130
Why?
Community Health Services
1
2019
229
0.130
Why?
Adult
6
2026
41087
0.130
Why?
Hypophosphatemia
1
2017
16
0.120
Why?
Alleles
1
2020
907
0.120
Why?
Controlled Clinical Trials as Topic
1
2016
26
0.120
Why?
Radioimmunoassay
1
2016
162
0.120
Why?
Risk
1
2019
920
0.120
Why?
Colorado
3
2024
4595
0.120
Why?
Infant Formula
1
2017
71
0.120
Why?
Disease Management
1
2020
651
0.120
Why?
Bone Diseases
1
2017
60
0.120
Why?
Influenza, Human
1
2022
640
0.120
Why?
Caregivers
1
2025
1080
0.110
Why?
Patient Education as Topic
1
2021
770
0.110
Why?
Practice Guidelines as Topic
1
2023
1591
0.110
Why?
Prospective Studies
2
2026
8123
0.110
Why?
Pediatrics
2
2024
1124
0.110
Why?
Abatacept
1
2014
56
0.100
Why?
Vitamin B Complex
1
2014
39
0.100
Why?
Patient Reported Outcome Measures
1
2019
516
0.100
Why?
Early Medical Intervention
1
2014
59
0.100
Why?
Diabetic Nephropathies
1
2017
320
0.100
Why?
Niacinamide
1
2014
103
0.100
Why?
Blood Glucose Self-Monitoring
1
2019
704
0.100
Why?
Health Status
1
2019
827
0.100
Why?
Prevalence
3
2026
2861
0.100
Why?
Pediatric Obesity
1
2020
635
0.090
Why?
Secondary Prevention
1
2014
248
0.090
Why?
Immunoconjugates
1
2014
138
0.090
Why?
Autoantigens
1
2015
426
0.090
Why?
Chronic Disease
1
2019
1827
0.090
Why?
Primary Prevention
1
2014
222
0.090
Why?
B-Lymphocytes
1
2017
887
0.090
Why?
Genetic Predisposition to Disease
2
2025
2488
0.080
Why?
Treatment Outcome
1
2026
11821
0.080
Why?
Autoimmune Diseases
1
2014
467
0.080
Why?
Cross-Sectional Studies
2
2025
5899
0.070
Why?
Middle Aged
3
2025
36619
0.070
Why?
Consensus
2
2022
467
0.070
Why?
Risk Factors
1
2023
10921
0.070
Why?
Biomarkers
1
2019
4340
0.070
Why?
Randomized Controlled Trials as Topic
1
2014
1763
0.070
Why?
Societies, Medical
2
2024
907
0.060
Why?
Sensitivity and Specificity
2
2022
1998
0.060
Why?
Receptors, Antigen, T-Cell
2
2022
677
0.060
Why?
Infant, Newborn
1
2015
6460
0.050
Why?
CD3 Complex
1
2023
113
0.050
Why?
Seroepidemiologic Studies
1
2023
171
0.050
Why?
T-Lymphocytes
2
2023
2012
0.040
Why?
Hypoglycemia
1
2026
490
0.040
Why?
Receptors, Antigen, T-Cell, alpha-beta
1
2022
330
0.040
Why?
Perception
1
2023
373
0.040
Why?
Databases, Factual
1
2026
1493
0.040
Why?
High-Throughput Nucleotide Sequencing
1
2022
539
0.040
Why?
Double-Blind Method
1
2023
2070
0.030
Why?
Antibodies, Viral
1
2023
689
0.030
Why?
International Cooperation
1
2018
193
0.030
Why?
ROC Curve
1
2019
617
0.030
Why?
Rickets
1
2017
8
0.030
Why?
Follow-Up Studies
1
2026
5439
0.030
Why?
Phosphorus
1
2017
89
0.030
Why?
Alkaline Phosphatase
1
2017
144
0.030
Why?
Aged
1
2016
26432
0.030
Why?
Anxiety
1
2023
1125
0.030
Why?
Parents
1
2023
1394
0.030
Why?
Predictive Value of Tests
1
2019
2113
0.020
Why?
Longitudinal Studies
1
2019
3017
0.020
Why?
Calcium
1
2017
1181
0.020
Why?
Practice Patterns, Physicians'
1
2018
1408
0.020
Why?
Surveys and Questionnaires
1
2019
6073
0.010
Why?
Animals
1
2015
38106
0.010
Why?
Simmons's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description
Physical Neighbors Expand Description
_

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)